This first article, part of a three-post series, focusses on need for such a meeting and underlines the impact of accelerated approvals in the field of Oncology.
COVID-19 Impact on Pharma: A Q2 Earnings Narrative
The COVID-19 pandemic has had a very strong impact on all global economies across multiple sectors. Its impact on the US Pharma industry was significant in the first quarter, causing most companies to adjust and realign their businesses in response to the outbreak. The pandemic not only had a direct impact on Q1 revenues, but also affected overall drug development …
Strategic Considerations for a World in Flux
Before COVID-19 transpired executives were concerned with their strategic assumptions and the results of getting them wrong. A February 2020 Gartner study cited lack of confidence in strategic assumptions as the leading corporate risk among senior executives across a diverse set of industries and global geographies in Q4 2019. A strategic assumption can be defined as the unstated belief that something is likely to occur to enable an achievable strategic goal. Depending on the …
COVID-19 Impact on Pharma: A Q1 Earnings Narrative
The COVID-19 outbreak generated widespread concern over how pharmaceutical, biotechnology, and medtech companies would cope with stringent national and regional lockdowns. Financial results from Q1 provide the first indicator of how this public health crisis will impact this industry and what the future may hold. By early May, earnings for most of the significant players in the pharma industry had been announced, …
Connecting Information Silos
Over the last several years there have been a number of interesting articles written about breaking down information silos, in fact, I have even used that term myself in the past. However, the more I work with clients attempting to overcome the information silo dilemma, I am convinced the emphasis should instead be on connecting information silos. Let’s face it, …
Six Degrees of Connection
Improve the ROI and sustainability of competitive intelligence in your organization by linking CI to Strategy using six analytical tools. In order to increase the ROI, and thus the sustainability, of Competitive Intelligence (CI) within your organization, it is essential to link research with strategy. While there is a growing dialogue concerning the need to increase the impact of CI …
Think Like the Competitor, Act Like the Competitor, Beat the Competitor
How many of you remember this dialogue? If you don’t know what a dial-up modem sounds like, you are probably too young to remember this movie. Scientist: General, are you prepared to destroy the enemy? General: You betcha! Scientist: Do you think they know that? General: I believe we’ve made that clear enough. Scientist: Then don’t! Tell the President to …
What’s After Next
Leveraging competitive intelligence to identify innovation white space Today many companies are surveying the market and asking themselves, “What can we make next, how can we improve our product and what would be innovative?” ‘What’s next?’ can often lead to incremental innovation, continued competition, and a lack of differentiation. Instead we should be asking, ‘What’s after next?’ Leveraging competitive intelligence, …
Threat Matrix
Several years ago, two American astronomers, Marcus Wolf and Leo Biederman, working on a mountain top in Arizona, saw something in the night sky that caused them great concern. A comet. But the comet was, well… There was a remote possibility that the comet was on a path that could bring it into direct contact with the Earth. Now we …
Threat Indicator Analysis
This is a series of six blog posts designed to provide analytical tools that will help competitive intelligence practitioners link CI to strategy. If It Is Good Enough for the CIA… While serving in Kuwait as a counter-terrorist agent for the US Government, one of my responsibilities was to detect, evaluate and report on potential terrorist threats in the region. …
- Page 1 of 2
- 1
- 2